PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-228

  1. 118 Posts.
    lightbulb Created with Sketch. 14
    I mentioned PAR to a respected boutique fund manager about 6 months ago. The first question was "at what stage are they at with trials and approvals?". A successful Phase 3 was a mandatory criterion before they would consider (but I hoped he took a look in any case - the SP of the one he recommended I take a look at in response has gone backwards!). So yes - this was confirmation for me that Phase 3 success in OA will put us in a new league as far as fund management industry.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.